Genomic Health Inc (GHDX) - Financial and Strategic SWOT Analysis Review

September 2020 | 47 pages | ID: G2A06443E90EN
GlobalData

Abstracts

Genomic Health Inc (GHDX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Genomic Health Inc (Genomic Health) is a provider of genomic-based diagnostic tests and clinical laboratory services for the diagnosis of cancer. The company’s commercial product portfolio comprises Onco type DX breast cancer test, Onco type DX colon cancer test, Onco type DX prostate cancer test and Oncotype SEQ Liquid Select liquid biopsy mutation panel. Genomic Health develops these products using its Oncotype IQ Genomic Intelligence Platform, a technology which uses RT-PCR approach to improve cancer treatment decisions. The company has operations in North America, Europe and Asia through direct offices, subsidiaries and distributors. Genomic Health is headquartered in Redwood City, California, the US.

Genomic Health Inc Key Recent Developments

Nov 11,2019: Exact Sciences completes acquisition of Genomic Health for $2.8bn
Jul 30,2019: Exact Sciences to acquire Genomic Health for $2.8bn
Jul 29,2019: Genomic Health reports 19% revenue growth and record profit in second quarter 2019, raises full-year guidance
May 07,2019: Genomic Health announces first quarter 2019 financial results
Feb 20,2019: Genomic Health reports record 2018 fourth quarter and year-end financial results and provides 2019 financial guidance

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Genomic Health Inc - Key Facts
Genomic Health Inc - Key Employees
Genomic Health Inc - Key Employee Biographies
Genomic Health Inc - Major Products and Services
Genomic Health Inc - History
Genomic Health Inc - Company Statement
Genomic Health Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Genomic Health Inc - Business Description
Geographical Segment: Outside of the US
Performance
Geographical Segment: The US
Performance
R&D Overview
Genomic Health Inc - Corporate Strategy
Genomic Health Inc - SWOT Analysis
SWOT Analysis - Overview
Genomic Health Inc - Strengths
Genomic Health Inc - Weaknesses
Genomic Health Inc - Opportunities
Genomic Health Inc - Threats
Genomic Health Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Genomic Health Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Genomic Health Inc, Medical Equipment, Deals By Type, 2014 to YTD 2020
Genomic Health Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Nov 11, 2019: Exact Sciences completes acquisition of Genomic Health for $2.8bn
Jul 30, 2019: Exact Sciences to acquire Genomic Health for $2.8bn
Jul 29, 2019: Genomic Health reports 19% revenue growth and record profit in second quarter 2019, raises full-year guidance
May 07, 2019: Genomic Health announces first quarter 2019 financial results
Feb 20, 2019: Genomic Health reports record 2018 fourth quarter and year-end financial results and provides 2019 financial guidance

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Genomic Health Inc, Key Facts
Genomic Health Inc, Key Employees
Genomic Health Inc, Key Employee Biographies
Genomic Health Inc, Major Products and Services
Genomic Health Inc, History
Genomic Health Inc, Other Locations
Genomic Health Inc, Subsidiaries
Genomic Health Inc, Key Competitors
Genomic Health Inc, Ratios based on current share price
Genomic Health Inc, Annual Ratios
Genomic Health Inc, Annual Ratios (Cont...1)
Genomic Health Inc, Interim Ratios
Genomic Health Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Genomic Health Inc, Medical Equipment, Deals By Type, 2014 to YTD 2020
Genomic Health Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Genomic Health Inc, Performance Chart (2014 - 2018)
Genomic Health Inc, Ratio Charts
Genomic Health Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Genomic Health Inc, Medical Equipment, Deals by Type, 2014 to YTD 2020

COMPANIES MENTIONED

Roche Diagnostics International Ltd
Qiagen NV
Decipher Biosciences Inc
Personal Genome Diagnostics Inc
NanoString Technologies Inc
Siemens AG
NeoGenomics Inc
Metamark Genetics Inc
Exact Sciences Corp
Natera Inc
Guardant Health Inc
Danaher Corp
Bio Techne Corp
bioTheranostics Inc
BGI Genomics Co Ltd
MDxHealth SA
Agendia Inc
OPKO Health Inc
Myriad Genetics Inc
Grail Inc
Hologic Inc